Company Name:Boomerang Brands LLC
Triple Receptor Agonism Published research has characterized retatrutide's activity at three distinct receptors: GIP, GLP-1, and glucagon receptors
According to data from the SURPASS clinical trial program, patients taking tirzepatide 15 mg lost approximately 5 to 7 percent more body weight than those taking semaglutide 1 mg over 40 weeks
Contact your provider if it persists, worsens, or occurs with vomiting, dehydration, severe abdominal pain, or significant bowel changes
Step 7: Remove and Dispose of the Needle Remove the needle from your skin
A more recent study published in December 2023 found a similar result in tirzepatide, the main ingredient in Mounjaro and Zepbound